Originally published in the Hartford Courant, this op-ed examines Connecticut's Public Act 26-108 and its implications for psychedelic-assisted therapy, evidence-based healthcare innovation, and patient access.

Oregon’s psilocybin services program offers an early case study for states considering how to expand access to psychedelics while maintaining responsible safety protections.